These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25942451)

  • 21. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.
    Qiao Q; Li Y; Chen Z; Wang M; Reinberg D; Xu RM
    J Biol Chem; 2011 Mar; 286(10):8361-8368. PubMed ID: 21196496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NSD2 as a Promising Target in Hematological Disorders.
    Azagra A; Cobaleda C
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
    Nakshatri H; Appaiah HN; Anjanappa M; Gilley D; Tanaka H; Badve S; Crooks PA; Mathews W; Sweeney C; Bhat-Nakshatri P
    Cell Death Dis; 2015 Jan; 6(1):e1608. PubMed ID: 25611383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2.
    Yamada-Okabe T; Imamura K; Kawaguchi N; Sakai H; Yamashita M; Matsumoto N
    Biochem Biophys Res Commun; 2010 Nov; 402(2):335-9. PubMed ID: 20946879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases.
    Yuan G; Ma B; Yuan W; Zhang Z; Chen P; Ding X; Feng L; Shen X; Chen S; Li G; Zhu B
    J Biol Chem; 2013 Oct; 288(43):30832-42. PubMed ID: 24019522
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
    Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase.
    Rathert P
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nizp1, a novel multitype zinc finger protein that interacts with the NSD1 histone lysine methyltransferase through a unique C2HR motif.
    Nielsen AL; Jørgensen P; Lerouge T; Cerviño M; Chambon P; Losson R
    Mol Cell Biol; 2004 Jun; 24(12):5184-96. PubMed ID: 15169884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nizp1 is a specific NUP98-NSD1 functional interactor that regulates NUP98-NSD1-dependent oncogenic programs.
    Berardi A; Botrugno OA; Quilici G; Manteiga JMG; Bachi A; Tonon G; Musco G
    FEBS J; 2023 Apr; 290(7):1782-1797. PubMed ID: 36271682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65.
    Lu T; Jackson MW; Wang B; Yang M; Chance MR; Miyagi M; Gudkov AV; Stark GR
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):46-51. PubMed ID: 20080798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wolf-Hirschhorn syndrome candidate 1-like 1 epigenetically regulates nephrin gene expression.
    Ito Y; Katayama K; Nishibori Y; Akimoto Y; Kudo A; Kurayama R; Hada I; Takahashi S; Kimura T; Fukutomi T; Katada T; Suehiro J; Beltcheva O; Tryggvason K; Yan K
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1184-F1199. PubMed ID: 28228401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation.
    Khella MS; Schnee P; Weirich S; Bui T; Bröhm A; Bashtrykov P; Pleiss J; Jeltsch A
    J Biol Chem; 2023 Jun; 299(6):104796. PubMed ID: 37150325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
    Coussens NP; Kales SC; Henderson MJ; Lee OW; Horiuchi KY; Wang Y; Chen Q; Kuznetsova E; Wu J; Chakka S; Cheff DM; Cheng KC; Shinn P; Brimacombe KR; Shen M; Simeonov A; Lal-Nag M; Ma H; Jadhav A; Hall MD
    J Biol Chem; 2018 Aug; 293(35):13750-13765. PubMed ID: 29945974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
    Peri S; Izumchenko E; Schubert AD; Slifker MJ; Ruth K; Serebriiskii IG; Guo T; Burtness BA; Mehra R; Ross EA; Sidransky D; Golemis EA
    Nat Commun; 2017 Nov; 8(1):1772. PubMed ID: 29176703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation.
    García-Carpizo V; Sarmentero J; Han B; Graña O; Ruiz-Llorente S; Pisano DG; Serrano M; Brooks HB; Campbell RM; Barrero MJ
    Sci Rep; 2016 Sep; 6():32952. PubMed ID: 27604143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
    Toyokawa G; Cho HS; Masuda K; Yamane Y; Yoshimatsu M; Hayami S; Takawa M; Iwai Y; Daigo Y; Tsuchiya E; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
    Neoplasia; 2011 Oct; 13(10):887-98. PubMed ID: 22028615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome.
    Nimura K; Ura K; Shiratori H; Ikawa M; Okabe M; Schwartz RJ; Kaneda Y
    Nature; 2009 Jul; 460(7252):287-91. PubMed ID: 19483677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence-associated epigenomic remodeling.
    Tanaka H; Igata T; Etoh K; Koga T; Takebayashi SI; Nakao M
    Aging Cell; 2020 Jul; 19(7):e13173. PubMed ID: 32573059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the Epigenetic Oncogene MMSET and Inhibition by N-Alkyl Sinefungin Derivatives.
    Tisi D; Chiarparin E; Tamanini E; Pathuri P; Coyle JE; Hold A; Holding FP; Amin N; Martin AC; Rich SJ; Berdini V; Yon J; Acklam P; Burke R; Drouin L; Harmer JE; Jeganathan F; van Montfort RL; Newbatt Y; Tortorici M; Westlake M; Wood A; Hoelder S; Heightman TD
    ACS Chem Biol; 2016 Nov; 11(11):3093-3105. PubMed ID: 27571355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Scalable Platform for Producing Recombinant Nucleosomes with Codified Histone Methyltransferase Substrate Preferences.
    McDevitt PJ; Schneck JL; Diaz E; Hou W; Huddleston MJ; Matico RE; McCormick PM; Kirkpatrick RB
    Protein Expr Purif; 2019 Dec; 164():105455. PubMed ID: 31306746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.